1. Kindly explain regarding how the sample size of 2000 has been calculated for the study. 2. The details of how many children with normal visual function and how many with abnormal visual function would be used in the AI training phase can be added. 3. Who would be carrying out the DIVE examination. Would the tests be done by Optometrists. More clear methodology details can be added. 4. Has a pilot test been done using DIVE. If so, please provide details. 5. There are no details regarding the technical aspects of how the AI algorithm will be developed and what outputs would be provided by the algorithm 6. If the study has funding details, kindly provide them.
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GENERAL COMMENTS
Authors are planning to develop AI algorism for estimating children's visual prognosis.
Variables: Usually AI means some deep architecture of machine learning. There is no bigdata, such as images, sounds, videos, etc. Isn't it enough to use multivariate analysis? Why do the authors use AI? What types of AI will the authors use? What is the definition of the AI used in this manuscript?
Sample size: Visual acuity is influenced by fellow eye. Isn't it necessary to include fellow eye visual acuity? I think 4000 records will not be available without the fellow eye visual acuity.
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1
Reviewer Name: Dr. Ramachandran Rajalakshmi 1. Kindly explain regarding how the sample size of 2000 has been calculated for the study.
The initial estimation of the 2000 participants required was based on previous studies. However, sample size will be adjusted along the recruitment based on the learning curves of the model. We have included more detailed information in the manuscript.
2. The details of how many children with normal visual function and how many with abnormal visual function would be used in the AI training phase can be added.
We have added this information to the Sample size section. Big data does not necessarily involve images, sounds, and videos. We do have very large data sets of gaze data (i.e. gaze positions every 6.7msec all over the visual test), which can be thought of as a stream of information similar to a video, which we aim to analyse to find patterns and associate them to normal or abnormal visual development and to certain specific pathologies. Analysing these gaze data is an extremely complex problem because of the variability among patients, even among those with the same age and visual development. A simple multivariate analysis would be unable to take advantage of all the information included on the gaze data logs, and to generalize among patients with different characteristics.
More details about the AI algorithms used have been included in the manuscript.
8. Sample size: Visual acuity is influenced by fellow eye. Isn't it necessary to include fellow eye visual acuity? I think 4000 records will not be available without the fellow eye visual acuity.
All the assessments will be performed binocularly and monocularly, with the fellow eye covered. Since both eyes can have a different visual development with different pathologies, both eyes will be considered independently for the monocular assessment.
Sample size section has been improved, and more information about its estimation is included in the manuscript. 
